LP

Lewis Pell

North America, Pennsylvania, United States, Horsham

Description

Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 1...

Investor Profile

Lewis Pell has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in Israel, United States.
  • Strong thematic focus on Health Care, Medical Device, Therapeutics.

Stage Focus

  • Series Unknown (50%)
  • Post Ipo Equity (50%)

Country Focus

  • Israel (50%)
  • United States (50%)

Industry Focus

  • Health Care
  • Medical Device
  • Therapeutics
  • Biotechnology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lewis Pell frequently co-invest with?

Israel Biotech Fund
Asia, HaMerkaz, Israel, Rehovot
Co-Investments: 1
Laborie Medical Technologies
North America, New Hampshire, United States, Portsmouth
Co-Investments: 1
A
Europe, Worcestershire, United Kingdom, Bromsgrove
Co-Investments: 1
Trendlines Group
Asia, HaZafon, Israel, Misgav
Co-Investments: 1

What are some of recent deals done by Lewis Pell?

Vensica Medical

Misgav, HaZafon, Israel

Ultrasound Based Catheter For Improved Drug Delivery To The Bladder

Health CareMedical DeviceTherapeutics
Series UnknownNov 1, 2021
Amount Raised: $16,000,000
Vision Sciences

Orangeburg, New York, United States

Vision Sciences, a medical device company, develops flexible endoscopes as a control solution to decrease the risk of cross-contamination.

BiotechnologyHealth CareMedical
Post Ipo EquityFeb 1, 2011
Amount Raised: $10,500,000